Bills: HF4493, HF3133, HF4595, HF4143, HF4142, HF3756, HF4289, HF1724, HF2291, HF4568, HF4547

Keywords: opioid use disorder, OUD, medication-assisted treatment, MAT, pharmacist prescribing, pharmacy practice, controlled substances, Schedule III, Schedule IV, Schedule V, DEA registration, Board of Pharmacy, substance use disorder, addiction treatment, buprenorphine, naltrexone, harm reduction, prescription authority, pharmacist intern, Minnesota pharmacy law

Transcript Highlights:

• Naltrexone, also sometimes known as Vivitrol, is used to help people who have an opioid or alcohol addiction
• And you have provided in the current fiscal year $5.5 million for the Naltrexone, the one that I mentioned
• year 2014-15, the legislature first appropriated that $5.5 million in GR for the extended-release naltrexone
• covered the additional drugs that Eric mentioned: buprenorphine, the injectable buprenorphine, oral naltrexone
• Now we are adding this year the acamprosate and the oral naltrexone, and those are oral drugs, which

Summary: The Appropriations Committee on Criminal and Civil Justice met to continue its review of performance measurement in the criminal justice system. The first presentation, from State Courts Administrator Eric McClure, described how the court system uses multiple data sources to track filings, dispositions, clearance rates, workload, and support services, and how those data inform judge need, budget requests, resource allocation, and court administration. He also discussed ongoing efforts to improve case-level reporting, the use of case management systems in trial and appellate courts, and performance efforts in problem-solving courts and civil case management. McClure noted that the legislature provides dedicated funding for problem-solving courts and for medication-assisted treatment, and that the courts are required to report outcomes and monitor compliance with contract requirements. Melanie Brown-Whor of the Florida Behavioral Health Association then reviewed the medication-assisted treatment program funded through the courts budget. She said the program combines medication with counseling and behavioral supports, serves people involved in or at risk of criminal justice involvement, and has expanded over time to include additional medications and more counties. She reported improved engagement and retention, with more than 10,000 people screened over five years, about 9,200 receiving medication, and over 6,600 successfully discharged. Senators asked about racial and ethnic demographics, hospital referrals, and how services are delivered; Brown-Whor explained that local community providers deliver treatment under contract and that the program is working to improve data reporting and consistency. The Department of Law Enforcement then presented on investigations, forensics, and criminal justice information services. Deputy Commissioner Vaden Pollard outlined FDLE’s strategic plan and major investigative priorities, including cybercrime, targeted violence, crimes against children, mutual aid, and the SAFE fentanyl eradication program. He said SAFE has led to major seizures, arrests, and a reported decline in fentanyl deaths. Director Jason Bundy described FDLE’s forensic laboratory operations, DNA and rapid DNA capabilities, cold case and missing persons work, and the staffing and turnaround-time challenges tied to complex evidence testing. Director Lucy Saunders reviewed FDLE’s criminal history, biometric, incident-based crime reporting, and criminal justice transparency systems, noting that Florida is still transitioning agencies from summary reporting to incident-based reporting. The committee raised questions about Rapid DNA deployment, cold case coordination, and the slow pace of NIBRS/FIBRS adoption. No votes were taken, and the meeting adjourned after the presentations and questions.

Transcript Highlights:

• Interventions for alcohol: we have one medication that has a good amount of evidence, and that's naltrexone
• And then naltrexone is known as naltrexone if you take it as a daily oral medication.
• Naltrexone is known as naltrexone if you take it as a daily oral medication, but if you do the monthly

Keywords: 959, house, all

Transcript Highlights:

• standard of care will need it or end up using medications for opioid use disorder, but methadone naltrexone
• So, is there a reason you're promoting methadone as opposed to naltrexone? or buprenorphine?
• That can mean methadone, buprenorphine, or naltrexone, I will say.

Transcript Highlights:

• The naltrexone, Vivitrol.
• heard that one of the drugs being smuggled in was one of the treatment drugs, not naloxone, but naltrexone

Transcript Highlights:

• Interventions for alcohol: we have one medication that has a good amount of evidence, and that's naltrexone
• And then naltrexone is known as naltrexone if you take it as a daily oral medication, but if you do the

Summary: The task force meeting opened with new leadership announcements, including Senator Nick Schroer thanking outgoing chair Representative John Black and naming Representative Del Taylor as vice chair. After some initial technical difficulties with audio and Zoom, members reviewed the task force’s statutory charge under Missouri law: to hold hearings on substance use, explore solutions, draft or modify legislation, and produce recommendations for prevention and treatment. The chair said the goal for this year is to develop concrete legislative ideas for the next session, with hearings focused first on field experts and later on alternative therapies and the Department of Mental Health. Dr. Rachel Winograd gave the first major presentation, describing Missouri’s overdose crisis as increasingly complex and driven primarily by fentanyl, now compounded by xylazine and metatomidine. She said overdose deaths have declined for a third straight year, with preliminary 2025 data around 1,200 deaths, and attributed the decline to a smaller fentanyl supply, wider naloxone availability, and fewer young people entering use. Her main recommendations were to focus on reducing harm rather than trying to eliminate drug use, expand evidence-based medications for opioid use disorder—especially methadone and buprenorphine—improve access to naloxone, and loosen methadone regulations, including take-home doses, the federal 72-hour rule, and broader methadone units. She also emphasized that peer support, housing, transportation, and other practical supports matter, and noted that naloxone can still reverse fentanyl overdoses even when tranquilizers are present. Dr. Heidi Miller, the state medical director, followed with two recommendations: integrate substance use disorder care into whole-person health care and follow the science when considering substance-related legislation. She argued that primary care, maternal health, workforce training, EMS, public health, and methadone access should all be part of a coordinated model, and said reimbursement should support teams rather than isolated providers. She also urged stronger enforcement of parity between behavioral health/SUD and physical health coverage, and highlighted tobacco and alcohol as major, under-addressed causes of death in Missouri. Dr. Doug Burgess then reinforced the need for a coordinated continuum of care, comparing substance use treatment to the seamless system used for heart attacks, and said patients should have standardized assessment, discharge planning from day one, transition coordinators, peer recovery coaches, and better information-sharing between levels of care. Members asked questions about relapse, treatment court, EMS referral barriers, reimbursement, and whether buprenorphine can be started in the field; no votes were taken, and the meeting ended with plans to continue hearing testimony and use it to shape future policy recommendations.

Transcript Highlights:

• These medications, buprenorphine, methadone, and extended-release naltrexone, are a gold standard for

Keywords: 1183, house

Transcript Highlights:

• Robert decided, after multiple admissions related to fentanyl, to receive Depo Naltrexone.
• The medications, buprenorphine and naltrexone, reduce overdose risk.

Bills: HB712, HB722, HB946, HB1687, HB1809, HB1899, HB2528, HB2583, HB2741, HB2750, HB3021, HB3150, HB3265, HB3658, HB3812, HB3960, HB4392, HB4432

Keywords: prostate cancer, health benefit plans, insurance coverage, cost sharing, preventive health care, auto insurance, total loss evaluation, disclosure, insurance materials, vehicle appraisal, HB 946, Texas Insurance Code, automobile insurance claims, oral release, written release, settlement agreement, claim release, property damage, bodily injury, psychological injury

Transcript Highlights:

• The medication in naltrexone is very beneficial in cutting down the drinking by 30%.
• And if medications can bring a 30% decrease, especially naltrexone, it can make a huge impact.

Summary: The meeting focused on Missouri’s substance use prevention and treatment system, with repeated emphasis on recovery support services, peer support, recovery housing, transportation, and harm reduction. Dan Haniken of Into Action described his own recovery from addiction and incarceration and argued that treatment alone is not enough; he urged greater investment in recovery housing, peer support, employment, and community-based supports that help people stay sober and avoid relapse. Members asked about funding sources, program capacity, referrals, treatment court, transportation, and how Into Action supports people on medication-assisted treatment (MAT). Haniken said the organization is funded through a mix of federal, state, county, city, foundation, and private donations, and that housing and transportation remain major barriers, especially because support is often funded for too short a period compared with the longer time people need to stabilize. Matt Cushman of the Raytown Fire Protection District gave a strong endorsement of harm reduction, including naloxone distribution, syringe service programs, and broader decriminalization of harm reduction tools. He argued that stigma is a major barrier to care and that Missouri should expand access to clean needles, test strips, and other services, while also improving access to MAT in jails and communities. Committee members questioned the evidence base, the role of faith-based providers, and whether safe consumption sites should be pursued; Cushman said syringe exchange decriminalization should be the immediate priority, while safe consumption sites are a longer-term issue. He also described community paramedicine and mobile integrated health as valuable but funding-dependent, and said naloxone distribution is improving but still uneven, especially in rural and minority communities. Representatives from Central Ozarks Medical Center and Four Rivers Community Health Center highlighted the importance of peer support specialists, community health workers, care coordinators, and wraparound services in rural health centers. COMC’s Morgan McClure and Monet Lehman described a jail reentry program in Pulaski County, with Lehman sharing her trauma and recovery story and explaining how she helps incarcerated people prepare for release with housing, employment, benefits, transportation, and treatment connections. Four Rivers’ Devon Polarys and Cassandra Trout said their CEO would change Missouri policy to allow FQHCs to receive reimbursement for peer support and community health worker services similar to CCBHCs, arguing that these roles are essential for addressing barriers like transportation, housing, food insecurity, and insurance. Members discussed confusion over reimbursement rules, the differences between FQHCs and CCBHCs, and the need for better funding and clearer policy for peer and community health worker services. No votes were taken; the discussion ended with a suggestion to bring in a subject matter expert on community health workers for a future session.

Transcript Highlights:

• Robert decided after multiple admissions related to fentanyl to receive Depot naltrexone.
• The medications, buprenorphine and naltrexone reduce overdose risk, improve outcomes, and ultimately

Transcript Highlights:

• year, 2014, 15, the legislature first appropriate that 5.5 million in GR for the extended release, naltrexone

Keywords: 999, senate, all

Transcript Highlights:

• The medication in naltrexone is very beneficial in cutting down the drinking by 30%.
• die every year from alcohol use disorder—and if medications can bring a 30% decrease, especially naltrexone

Keywords: 959, house, all

Transcript Highlights:

• These medications, buprenorphine, methadone, and extended-release naltrexone, are gold standard for care
• These medications, buprenorphine, methadone, and extended-release naltrexone, are gold standard for care
• These medications, buprenorphine, methadone, and extended-release naltrexone, are gold standard for care

Bills: HF362, HF2590, HF2760, HF3444

Keywords: massage therapy, Asian bodywork therapy, massage therapist, Asian bodywork therapist, licensure, professional licensing, health occupations, Department of Health, commissioner of health, advisory council, protected title, unlicensed practice, scope of practice, consumer protection, background check, professional liability insurance, continuing education, credentialing examination, state preemption, municipal regulation

Transcript Highlights:

• disorder, where you're getting, you know, one type of service and then maybe it switches to, like, naltrexone
• disorder where you're getting, you know, one type of service and then maybe it switches to like naltrexone

Summary: The Assembly Health Committee met on April 22 and took up a special order of bills focused largely on prior authorization and utilization management in health care. The chair framed the discussion as part of a broader legislative effort to reduce delays and barriers to care, especially in behavioral health, chronic disease management, cancer treatment, and rehabilitation services. AB 384 by Assembly Member Connolly would prohibit prior authorization for inpatient mental health or substance use emergency admissions and related physician care; supporters said it would prevent dangerous delays in crisis care, while insurers and health plans warned about fraud, abuse, and ambiguity around residential treatment facilities. The bill was moved on a due pass as amended motion and passed the committee on a party-line style vote, with Republicans largely absent or not voting. The committee then heard AB 510 by Assembly Member Addis, which would require health plans, upon request, to provide a peer reviewer of the same or similar specialty when a treating provider appeals a prior authorization denial or modification. Supporters argued that specialty-matched review would make appeals fairer and more clinically informed; opponents said the requirement was too rigid and that timelines and electronic submission rules needed changes. After discussion about the need for timely, specialty-specific review, the bill was approved on a due pass as amended motion and placed on call. AB 539 by Assembly Member Schiavo would extend prior authorization approvals to one year or the duration of the physician’s prescribed treatment for chronic conditions; supporters cited repeated denials and treatment interruptions, while opponents raised concerns about overbreadth, fraud, and the need for shorter validity periods. The bill was also passed as amended and placed on call. The committee next considered AB 669 by Assembly Member Haney, which would bar concurrent and retrospective review for the first 28 days of medically necessary substance use disorder treatment and limit prior authorization for related outpatient medications. The bill was presented with a powerful personal story from Ryan Matlock’s mother about her son’s death after an insurer cut off treatment early; supporters said the measure would keep patients in care long enough to stabilize, while opponents argued it would reduce oversight and could allow lower-quality or non-evidence-based care. The bill was moved on a due pass as amended motion and placed on call. Finally, AB 512 by Assembly Member Harabedian would shorten prior authorization response times to 24 hours for urgent requests and 48 hours for non-urgent requests; supporters said delays can worsen outcomes, while opponents warned the timelines were unrealistic and could increase administrative burdens and safety issues. The bill was approved as amended and placed on call. AB 574 by Assembly Member Mark Gonzalez was then heard; it would allow up to 12 medically necessary physical therapy sessions for a new episode of care without prior authorization, with supporters emphasizing stroke and neurological recovery and opponents warning of reduced oversight and unnecessary care. The transcript ends during testimony on AB 574, before final action is shown.

Bills: SB6, SB62, SB74, SB90, SB104, SB119, SB132, SB133, SB135, SB182, SB185, SB193, SB207, SB217, SB229, SB233, SB260, SB262, SB280, SB281, SB300, SB306, SB378, SB382, SB393, SB403, SB422, SB427, SB431, SB434, SB442, SB452, SB456, SB468, SB472, SB487, SB503, SB6

Keywords: cloud seeding, Nevada, water conservation, agriculture, Desert Research Institute, victim compensation, hate crimes, property remediation, criminal justice, vulnerable persons, elections, voter registration, mail ballots, candidate eligibility, cybersecurity, education funding, teacher grants, classroom supplies, instructional support, specialized personnel